Rhode Island Hematology/Oncology Program — Woonsocket, Rhode Island

Rhode Island Hematology/Oncology Program is a clinical research site located in Woonsocket, Rhode Island, United States 02895-4720.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Rhode Island Hematology/Oncology Program has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Follicular Lymphoma.

Sponsors: Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Woonsocket

Browse all research sites in Rhode Island · View every site in Woonsocket

• Landmark Hospital
• CVS Health
• Landmark Medical Center
• Sanofi-Aventis Investigational Site Number 840095
• GSK Investigational Site
• Woonsocket Comprehensive Treatment Center
• Partners in Clinical Research
• Community Care Alliance (i.e., Community Mental Health Center)
• Thundermist Health Center
• Research Site
• Sojourner House

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hematology/Oncology Program?

Rhode Island Hematology/Oncology Program has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hematology/Oncology Program conducted?

Rhode Island Hematology/Oncology Program has 1 clinical trials on record, with 1 currently active. Their work covers Follicular Lymphoma.

Is Rhode Island Hematology/Oncology Program accredited by Crixeo Clinical Trials?

Rhode Island Hematology/Oncology Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hematology/Oncology Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.